Table 5. Blood cells counting (mean ± s).
| Group | WBC (×109/L) | RBC (×1012/L) | PLT (×109/L) |
|---|---|---|---|
| normal control group | 5.1 ± 5.3 | 3.0 ± 3.5 | 362.5 ± 54.3 |
| saline control group | 5.2 ± 0.9 | 3.4 ± 0.4 | 313.5 ± 69.4 |
| adriamycin group | 4.5 ± 0.7 | 3.6 ± 0.5 | 317.5 ± 58.4 |
| nuclide-alone group | 4.9 ± 0.7 | 3.2 ± 0.4 | 363.3 ± 79.4 |
| MFH-alone group | 4.7 ± 0.6 | 3.3 ± 0.7 | 327.7 ± 70.4 |
| nuclide-gene group | 4.7 ± 0.8 | 3.3 ± 0.8 | 318.1 ± 65.0 |
| nuclide-gene-MFH group | 4.8 ± 0.7 | 3.2 ± 0.3 | 326.0 ± 60.7 |
WBC, RBC and PLT have no differences between all the therapeutic groups and normal control group or saline control group (p > 0.05).